Del. Judge Ends 80K Pre-2026 Zantac Cases

By Emily Field

A Delaware state court on Monday dismissed more than 80,000 suits filed before December alleging that Boehringer Ingelheim's discontinued heartburn medication Zantac caused cancer, following a Delaware Supreme Court ruling on admissibility of the plaintiffs' experts.

Opinion attached | Read full article » | Save to favorites »

11th Circ. Backs FDA's Ban Over Drug Tester's Conviction

By Chart Riggall

The Eleventh Circuit on Monday backed a U.S. Food and Drug Administration order barring a former pharmaceutical worker from future interaction with the agency after she was convicted of lying during an investigation of her company, rejecting her bid for judicial review of the decision.

Opinion attached | Read full article » | Save to favorites »

'Gay Conversion' Ruling Nixes Telehealth Ban, 9th Circ. Told

By Craig Clough

An attorney representing a doctor and patient challenging California's law severely limiting interstate telehealth medical consultations urged a Ninth Circuit panel Monday to reverse a lower court's order dismissing the suit, saying the Supreme Court's recent decision nullifying Colorado's ban on "gay conversion therapy" applies to the case.

Read full article » | Save to favorites »

Hikma Tells Justices Cox Ruling Boosts 'Skinny Label' Case

By Ryan Davis

Hikma Pharmaceuticals USA Inc. told the U.S. Supreme Court on Monday that the justices' recent decision clearing an internet company in a copyright case bolsters the drugmaker's challenge to a patent suit over its generic version of an Amarin Pharma Inc. heart drug.

1 document attached | Read full article » | Save to favorites »

Mylan Can't Revive Copaxone Antitrust Claims Against Teva

By Bryan Koenig

A New Jersey federal judge sided Monday with a special master's recommendations to nix some of the parallel claims from Mylan and retailers like Walgreens accusing Teva of using regulatory deception, false advertising, improper rebates and more to delay generic competition to its Copaxone multiple sclerosis treatment.

2 documents attached | Read full article » | Save to favorites »

Legislative Update: Cannabis And Psychedelics Bill Roundup

By Sam Reisman

Massachusetts legislators sent a bill making numerous changes to the state's cannabis regulatory scheme to the governor, Oregon and Louisiana advanced legislation to expand medical marijuana access to seriously ill patients in healthcare facilities, and Virginia's governor approved legislation paving the way for medical psilocybin if the drug's federal status should change. Here are the major moves in cannabis and psychedelics legislation from the past week.

Read full article » | Save to favorites »

ITC Will Find Out If Imported Pain Patches Infringe Patent

By Jack McLoone

Imported over-the-counter lidocaine patches sold by five companies in the U.S. are facing possible exclusion orders after the U.S. International Trade Commission on Monday said it would open an investigation into claims that they infringe a patent on such patches.

6 documents attached | Read full article » | Save to favorites »

Chamber, Other Biz Groups Back Insulin Cos. At High Court

By Bryan Koenig

The U.S. Chamber of Commerce and other business groups urged the U.S. Supreme Court to take up an appeal from Sanofi-Aventis, Eli Lilly, Novo Nordisk and AstraZeneca, arguing the Second Circuit's revival of an antitrust suit risks opening up liability just for trade group membership.

2 documents attached | Read full article » | Save to favorites »

Retrial Ordered In $18M Heart Surgery Malpractice Case

By Chart Riggall

A Georgia state court judge has ordered a redo of a medical malpractice trial that landed an $18 million verdict for the family of a man who died weeks after surgery, ruling that her decision to not grant a mistrial over the family's opening statements "was unfair and led to a prejudicial error."

Order attached | Read full article » | Save to favorites »

Ill. Judge Wants More Proof To Recalculate Kickback Damages

By Lauraann Wood

An Illinois federal judge tasked with recalculating damages from a home health company's referral kickback scheme said Monday that she needs more complete and reliable evidence to help determine the appropriate amount, but allowed the government to continue offsetting Medicare payments as part of its judgment collection bid.

Read full article » | Save to favorites »

Abbott Urges Toss Of Relator, State Suits In FCA Recall Row

By Gianna Ferrarin

Abbott Laboratories urged a Michigan federal court to throw out litigation brought by whistleblowers and a group of states over the 2022 infant formula shortage, saying their respective complaints lacked the details necessary to support claims that it defrauded numerous healthcare programs.

2 documents attached | Read full article » | Save to favorites »

Roundup

NC High Court Snapshot: State Retirees Fight To Retain Class

By Hayley Fowler

The North Carolina Supreme Court in April will tackle a long-simmering fight over the state's obligations to provide health insurance to retired public employees, who are battling to keep their class status.

Read full article » | Save to favorites »

Cannabis Giant Verano Accused Of Mishandling Patient Info

By Jonathan Capriel

Cannabis giant Verano exposed the private data of at least half a million of its medical marijuana customers, according to a proposed class action removed to federal court that alleges the company turned ordinary receipts into "highly sensitive medical records."

Complaint attached | Read full article » | Save to favorites »

Texas GLP-1 Compounder Caused Mom's Death, Family Says

By Mark Payne

A Houston compounding pharmacy misled consumers by marketing its weight loss and diabetes drugs as safe and pharmaceutical-grade while selling contaminated medicines, a deceased Texas woman's family claims in a wrongful death lawsuit, alleging the drugs led to the woman's death. 

Complaint attached | Read full article » | Save to favorites »

AI Cardiac Imaging Co. Hits Ex-Consultant With IP Suit

By Elliot Weld

Artificial intelligence-powered cardiac imaging company Heartflow Inc. filed patent infringement and trade secret misappropriation claims on Monday against a competitor founded by a former consultant who, the company says, lifted technological trade secrets while he was under contract.

Complaint attached | Read full article » | Save to favorites »

Brief

FTC Ends Teen Height Growth Supplement Claims

By Jonathan Capriel

A supplement maker and its owners agreed to pay $750,000 to end claims they misled customers into thinking their products could make their children taller, the Federal Trade Commission announced on Monday.

Complaint attached | Read full article » | Save to favorites »

Brief

Ex-Med Spa Workers Settle Conn. Poaching Claims

By Aaron Keller

A Connecticut medical spa has settled a state court lawsuit accusing two former employees of luring clients and a colleague to a similar facility less than six miles away, court records show.

2 documents attached | Read full article » | Save to favorites »

Senior Housing, Healthcare REIT Seeks $1.1B Value In IPO

By Nate Beck

Real estate investment trust National Healthcare Properties Inc. said Monday that it is seeking to reach a valuation of about $1.1 billion in an upcoming initial public offering advised by Paul Weiss Rifkind Wharton & Garrison LLP, Greenberg Traurig LLP and Sidley Austin LLP.

Read full article » | Save to favorites »

Obesity Drugmaker Leads 2 Biotech Startups Eyeing IPOs

By Jade Martinez-Pogue

Two biotechnology startup companies on Monday filed plans for their public debuts, with obesity-focused Kailera Therapeutics planning to raise an estimated $500 million in its initial public offering and protein biomarker detection platform Alamar Biosciences planning to raise around $150 million.

Read full article » | Save to favorites »

Holland & Knight Adds Healthcare Pro In Dallas From Dykema

By Lynn LaRowe

Holland & Knight LLP announced Monday that it has deepened its healthcare transactions practice with a Dallas-based partner who came aboard from Dykema Gossett PLLC.

Read full article » | Save to favorites »

Opinion

State Bars Need To Get Specific About AI Confidentiality

Lawyers need to put actual client information into artificial intelligence tools to get their full value, but they cannot confidently do so until state bars offer clear, formal authority on which plan tiers of the three most popular generative AI tools are safe to use when sharing specific client details, says attorney Nick Berk.

Read full article » | Save to favorites »

DLA Piper Defeats Fired Associate's Claims Of Pregnancy Bias

By Pete Brush

A federal jury in Manhattan declined to award damages Monday to a former associate who says DLA Piper unlawfully fired her after she announced she was pregnant, absolving the BigLaw firm hours after tense closing arguments.

Read full article » | Save to favorites »

Q&A

Former Pardon Atty Says Trump's Clemency Grants Hurt DOJ

By Phillip Bantz

Former U.S. Department of Justice pardon attorney Liz Oyer spoke recently with Law360 about how the pardon process has changed, the impact the shift might have on the DOJ and how the system could be reformed.

Read full article » | Save to favorites »

DOJ Urges DC Circ. To Revive Trump EOs Targeting Firms

By Alison Knezevich

The D.C. Circuit should individually review each section of President Donald Trump's executive orders targeting four law firms, allowing certain portions to stand if others are blocked, the U.S. Department of Justice argued in a new filing urging the court to revive the measures.

Brief attached | Read full article » | Save to favorites »

Analysis

The Justices Had Their Say On Immunity. Is A DC Jury Next?

By Chris Villani

The limits of presidential immunity are once again set to be tested after a D.C. federal judge ruled President Donald Trump must face civil claims over the Jan. 6, 2021, riots, clearing the way for trial and potentially another high-stakes appeal to the U.S. Supreme Court.

Read full article » | Save to favorites »

Meta Pulls Some Attys' Social Media Addiction Ads

By Rachel Rippetoe

After losing a bellwether trial last month in one of a slew of cases from plaintiffs who claim to have been harmed by social media, Meta has begun removing ads from attorneys seeking clients with similar claims.

Read full article » | Save to favorites »

Brief

EEOC To Produce Law Firm DEI Letter Records By May 15

By Kelcey Caulder

The U.S. Equal Employment Opportunity Commission told a federal court Monday that it would give two law professors documents related to 20 letters the agency sent to law firms over their purported diversity, equity and inclusion practices by May 15.

Notice attached | Read full article » | Save to favorites »

Morgan & Morgan Sued Over Firing Amid Nevada Expansion

By Emily Sawicki

Personal injury titan Morgan & Morgan is facing allegations from a former firm attorney in California state court alleging the Golden State lawyer was pressured to file suits in neighboring Nevada despite having an inactive law license and no experience practicing there, and was then harassed and wrongfully fired over the filings.

Complaint attached | Read full article » | Save to favorites »

Atty Says Ogletree Can't Litigate Against Her In 2 Similar Cases

By Adrian Cruz

A Georgia attorney said Ogletree Deakins Nash Smoak & Stewart PC should be disqualified from serving as defense counsel in a discrimination suit she's working on while simultaneously litigating against her on behalf of her ex-employer in a similar matter.

Motion attached | Read full article » | Save to favorites »

NJ Man Who Sought To DQ US Atty Leadership To Plead Guilty

By Gina Kim

A criminal defendant who joined a pending bid to disqualify assistant U.S. attorneys overseeing the U.S. Attorney's Office for the District of New Jersey and escalated a constitutional challenge to its leadership structure told a federal judge Saturday he plans to plead guilty in his drug case. 

Letter attached | Read full article » | Save to favorites »

Catching Up With Delaware's Chancery Court

By Jarek Rutz

The Delaware Chancery Court's docket this past week featured a mix of high-stakes settlements, fast-moving deal litigation, governance disputes and a notable post-trial ruling involving fraud-tainted loans.

Read full article » | Save to favorites »